Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04798625 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Vaccine Response to COVID-19 Vaccines in Patients Using Immunosuppressive Medication

Study acronym: Nor-vaC
StatusActive, Not Recruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated February 23, 2024 (before its estimated February 15, 2026 completion). Its status may not reflect the trial's current state.

Record History

See every version on ClinicalTrials.gov ↗

  1. Enrollment target: estimated 1600 to confirmed 2300
    • Publications: 5 to 7
    v4
  2. Study description shortened, about 2 wordsv3
  3. Trial status: Recruiting to Active, Not Recruiting
    • Study description expanded, about 26 words
    • Site details revised at 2 of 2 sites
    v2
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Diakonhjemmet Hospital
25 trials monitored
See 1 trial at risk
Rheumatoid Arthritis
661 trials monitored
See 14 trials at risk
Crohn's Disease
642 trials monitored
See 34 trials at risk
Ulcerative Colitis
624 trials monitored
See 38 trials at risk
and 2 more diseases
The purpose of this study is to assess the strength and duration of the immunological response to COVID-19 vaccines in patients treated with immunosuppressive and/or immunomodulating medication for immune-mediated inflammatory diseases in rheumatology and gastroenterology and after a liver transplantation.
Trial Details
NCT Number NCT04798625
Lead Sponsor Diakonhjemmet Hospital
Collaborators: University Hospital, Akershus
Conditions
(from sponsor)		 Rheumatoid Arthritis, Psoriatic Arthritis, Spondyloarthritis, Crohn Disease, Ulcerative Colitis, Autoimmune Hepatitis, Liver Transplant; Complications
Related terms Arthritis, Psoriatic, Arthritis, Rheumatoid, Colitis, Ulcerative, Crohn Disease, Hepatitis, Autoimmune, Spondylarthritis
Enrollment 2,300 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov